Key facts
- This page summarizes Michael A. Rossi's Form 4 filing for HARVARD BIOSCIENCE INC (HBIO).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2023, 17:16.
Michael A. Rossi - 29 Dec 2022 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- HBIO
- Reported as of
- 29 Dec 2022
- Net transaction value
- -$25,398
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2023, 17:16:12 UTC
- Prior SEC filing
- 20 Jul 2022
- Next SEC filing
- 05 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Sirois, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael A. Rossi filed Form 4 for HARVARD BIOSCIENCE INC (HBIO) on 03 Jan 2023.
Change
- Previous filing in this sequence was filed on 20 Jul 2022.
- Current net transaction value: -$25,398.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HBIO
transaction
Common Stock
Tax liability
- Transaction value
- $8,063
- Shares
- -3,162
- Change %
- -1.2%
- Price
- $2.55
- Shares after
- 267,338
- Date
- 29 Dec 2022
- Ownership
- Direct
- Footnotes
- F1, F2
HBIO
transaction
Common Stock
Tax liability
- Transaction value
- $9,596
- Shares
- -3,763
- Change %
- -1.4%
- Price
- $2.55
- Shares after
- 263,575
- Date
- 29 Dec 2022
- Ownership
- Direct
- Footnotes
- F3, F4
HBIO
transaction
Common Stock
Tax liability
- Transaction value
- $7,739
- Shares
- -3,035
- Change %
- -1.2%
- Price
- $2.55
- Shares after
- 260,540
- Date
- 29 Dec 2022
- Ownership
- Direct
- Footnotes
- F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2022.
Footnote F2
Include (a) 20,681 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024, (b) 21,545 restricted stock units that will vest on June 11, 2023, (c) 12,821 restricted stock units that will vest on December 29, 2023, (d) 65,592 restricted stock units with performance based vesting conditions, (e) 10,772 restricted stock units that will vest on December 29, 2023, and (f) 135,927 shares of common stock beneficially owned by the Reporting Person.
Footnote F3
The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2022.
Footnote F4
Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above.
Footnote F5
The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2022.
Footnote F6
Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnotes (3) and (5) above.
SEC remarks
The Reporting Person resigned as Chief Financial Officer effective December 31, 2022.